Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 24, 2023 (Week 25)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 12,724 32,972 663,347 762,665
New England 516 1,469 20,716 24,002
Connecticut - 251 1,156 5,145
Maine 41 78 1,355 1,577
Massachusetts 365 717 13,967 12,979
New Hampshire 23 93 1,210 1,425
Rhode Island 87 688 2,399 2,292
Vermont - 37 629 584
Middle Atlantic 2,670 4,218 88,062 92,047
New Jersey 440 744 11,708 15,897
New York (excluding New York City) 812 1,032 19,364 18,715
New York City 567 1,457 31,024 30,806
Pennsylvania 851 1,234 25,966 26,629
East North Central 1,662 4,837 90,606 109,151
Illinois 107 1,517 24,207 33,738
Indiana 343 855 13,550 15,809
Michigan 217 975 15,386 20,380
Ohio 642 1,221 25,491 26,627
Wisconsin 353 560 11,972 12,597
West North Central 638 2,120 40,449 48,419
Iowa 183 334 6,499 7,159
Kansas 70 300 1,994 6,699
Minnesota 22 496 10,043 10,574
Missouri 350 729 14,775 15,260
Nebraska - 223 3,869 4,640
North Dakota - 92 1,017 1,726
South Dakota 13 125 2,252 2,361
South Atlantic 2,051 7,179 147,315 161,444
Delaware - 211 2,717 2,449
District of Columbia - 191 3,684 3,820
Florida - 2,791 51,673 48,704
Georgia 722 1,600 25,449 35,359
Maryland U NC U U
North Carolina 9 1,429 25,664 31,559
South Carolina 589 884 15,977 17,422
Virginia 717 984 20,182 19,963
West Virginia 14 110 1,969 2,168
East South Central 1,110 2,499 47,774 51,034
Alabama 591 973 16,509 14,690
Kentucky 384 511 7,567 8,546
Mississippi 135 526 8,399 9,104
Tennessee - 1,092 15,299 18,694
West South Central 510 4,926 69,444 112,565
Arkansas 154 378 7,547 8,669
Louisiana 306 801 16,315 17,555
Oklahoma 50 422 5,078 9,587
Texas - 3,397 40,504 76,754
Mountain 941 2,487 49,480 47,210
Arizona 495 917 18,795 19,661
Colorado 23 791 12,627 4,307
Idaho 8 154 2,688 2,318
Montana 39 112 1,698 1,958
Nevada 170 361 3,634 7,703
New Mexico 8 261 3,990 5,099
Utah 176 249 5,280 5,357
Wyoming 22 54 768 807
Pacific 2,626 5,046 109,501 116,793
Alaska 2 121 1,801 2,581
California 2,081 4,111 90,760 92,130
Hawaii - 3 - 64
Oregon 246 357 7,211 7,574
Washington 297 635 9,729 14,444
U.S. Territories 2 124 1,044 2,291
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico 2 124 1,044 2,291
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 7 26 66
Total 12,728 33,072 664,417 765,022
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.